{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T12:50:35Z","timestamp":1765975835271,"version":"3.38.0"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1097\/mpa.0b013e3181f5f1ab","type":"journal-article","created":{"date-parts":[[2010,9,24]],"date-time":"2010-09-24T17:15:27Z","timestamp":1285348527000},"page":"61-66","source":"Crossref","is-referenced-by-count":5,"title":["Tumor Suppressor Pdcd4 Is a Major Transcript That Is Upregulated During In Vivo Pancreatic Islet Neogenesis and Is Expressed in Both Beta-Cell and Ductal Cell Lines"],"prefix":"10.1097","volume":"40","author":[{"given":"William F.","family":"Ferris","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire E.","family":"Marriott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomader","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Landy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan C.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy M.","family":"Macfarlane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-13-20210212","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2337\/diab.44.3.249","article-title":"Dynamics of beta-cell mass in the growing rat pancreas. Estimation with a simple mathematical model.","volume":"44","author":"Finegood","year":"1995","journal-title":"Diabetes"},{"key":"R2-13-20210212","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1006\/cbir.2000.0683","article-title":"Brief occlusion of the main pancreatic duct rapidly initiates signals which lead to increased duct cell proliferation in the rat.","volume":"25","author":"Ferris","year":"2001","journal-title":"Cell Biol Int"},{"key":"R3-13-20210212","first-page":"54","article-title":"Islet neogenesis is stimulated by brief occlusion of the main pancreatic duct.","volume":"94","author":"Woodroof","year":"2004","journal-title":"SAMJ"},{"issue":"6","key":"R4-13-20210212","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1042\/BC20080191","article-title":"The tumour suppressor Pdcd4: recent advances in the elucidation of function and regulation.","volume":"101","author":"Lankat-Buttgereit","year":"2009","journal-title":"Biol Cell"},{"key":"R5-13-20210212","doi-asserted-by":"crossref","first-page":"4905","DOI":"10.1038\/sj.onc.1206710","article-title":"The transformation suppressor protein Pdcd4 shuttles between nucleus and cytoplasm and binds RNA.","volume":"22","author":"Bohm","year":"2003","journal-title":"Oncogene"},{"key":"R6-13-20210212","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1128\/MCB.23.1.26-37.2003","article-title":"The transformation suppressor Pdcd4 is a novel eukaryotic translation initiation factor 4A binding protein that inhibits translation.","volume":"23","author":"Yang","year":"2003","journal-title":"Mol Cell Biol"},{"key":"R7-13-20210212","first-page":"1387","article-title":"Alterations in the expression of PDCD4 in ductal carcinoma of the breast.","volume":"18","author":"Wen","year":"2007","journal-title":"Oncol Rep"},{"key":"R8-13-20210212","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1756-9966-28-71","article-title":"Programmed cell death 4 (PDCD4) suppresses metastastic potential of human hepatocellular carcinoma cells.","volume":"28","author":"Zhang","year":"2009","journal-title":"J Exp Clin Cancer Res"},{"key":"R9-13-20210212","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1582-4934.2008.00510.x","article-title":"MicroRNA and cancer-focus on apoptosis.","volume":"13","author":"Wang","year":"2009","journal-title":"J Cell Mol Med"},{"key":"R10-13-20210212","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1158\/1535-7163.103.3.2","article-title":"Characterization of programmed cell death 4 in multiple human cancers reveals a novel enhancer of drug sensitivity.","volume":"3","author":"Jansen","year":"2004","journal-title":"Mol Cancer Ther"},{"issue":"11-12","key":"R11-13-20210212","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1055\/s-2004-826168","article-title":"The development of beta-cell mass: recent progress and potential role of GLP-1.","volume":"36","author":"Stoffers","year":"2004","journal-title":"Horm Metab Res"},{"issue":"8","key":"R12-13-20210212","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1111\/j.1742-1241.2009.02086.x","article-title":"Treatment of type 2 diabetes with glucagon-like peptide-1 receptor agonists.","volume":"63","author":"Hansen","year":"2009","journal-title":"Int J Clin Pract"},{"key":"R13-13-20210212","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1210\/endo.143.8.8973","article-title":"Insulinotropic hormone glucagon-like peptide-1 differentiation of human pancreatic islet-derived progenitor cells into insulin-producing cells.","volume":"143","author":"Abraham","year":"2002","journal-title":"Endocrinology"},{"key":"R14-13-20210212","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/dmrr.357","article-title":"Glucagon-like peptide 1 inhibits cell apoptosis and improves glucose responsiveness of freshly isolated human islets.","volume":"19","author":"Egan","year":"2003","journal-title":"Diabetes Metab Res Rev"},{"issue":"5","key":"R15-13-20210212","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s00125-009-1322-y","article-title":"A role for islet neogenesis in curing diabetes.","volume":"52","author":"Pittenger","year":"2009","journal-title":"Diabetologia"},{"issue":"11","key":"R16-13-20210212","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1111\/j.1464-5491.2008.02556.x","article-title":"New potential treatments for protection of pancreatic B-cell function in type 1 diabetes.","volume":"25","author":"Cernea","year":"2008","journal-title":"Diabet Med"},{"issue":"14","key":"R17-13-20210212","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1007\/s00018-008-8100-8","article-title":"Rosiglitazone counteracts palmitate-induced beta-cell dysfunction by suppression of MAP kinase, inducible nitric oxide synthase and caspase 3 activities.","volume":"65","author":"Abaraviciene","year":"2008","journal-title":"Cell Mol Life Sci"},{"issue":"2","key":"R18-13-20210212","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/01.mpa.0000170682.66781.b9","article-title":"Glucocorticoid administration and brief occlusion of the main pancreatic duct are likely to increase islet mass by a similar mechanism.","volume":"31","author":"Ferris","year":"2005","journal-title":"Pancreas"},{"key":"R19-13-20210212","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1210\/endo-127-1-126","article-title":"Establishment of a pancreatic beta cell line that retains glucose-inducible insulin secretion: special reference to expression of glucose transporter isoforms.","volume":"127","author":"Miyazaki","year":"1990","journal-title":"Endocrinology"},{"issue":"2","key":"R20-13-20210212","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/00006676-200103000-00006","article-title":"ARIP cells as a model for pancreatic beta cell growth and development.","volume":"22","author":"Silver","year":"2001","journal-title":"Pancreas"},{"issue":"4","key":"R21-13-20210212","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s00125-006-0155-1","article-title":"Effects of rosiglitazone and metformin on pancreatic beta-cell gene expression.","volume":"49","author":"Richardson","year":"2006","journal-title":"Diabetologia"},{"issue":"2-3","key":"R22-13-20210212","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.mam.2005.12.003","article-title":"RNA integrity and the effect on the real-time qRT-PCR performance.","volume":"27","author":"Fleige","year":"2006","journal-title":"Mol Aspects Med"},{"issue":"3","key":"R23-13-20210212","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1006\/bbrc.2000.2665","article-title":"PPAR-gamma agonists increase vascular endothelial growth factor expression in human vascular smooth muscle cells.","volume":"271","author":"Yamakawa","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"R24-13-20210212","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1479-5876-6-32","article-title":"Transcriptional patterns, biomarkers and pathways characterizing nasopharyngeal carcinoma of Southern China.","volume":"6","author":"Fang","year":"2008","journal-title":"J Transl Med"},{"key":"R25-13-20210212","first-page":"597","article-title":"Expression of programmed cell death 4 and its clinicopathological significance in human pancreatic cancer.","volume":"27","author":"Ma","year":"2005","journal-title":"Zhongguo Yi Xue Ke Xue Yuan Xue Bao"},{"key":"R26-13-20210212","doi-asserted-by":"crossref","first-page":"6034","DOI":"10.1158\/0008-5472.CAN-04-2119","article-title":"Epidermal expression of the translation inhibitor programmed cell death 4 suppresses tumorigenesis.","volume":"65","author":"Jansen","year":"2005","journal-title":"Cancer Res"},{"key":"R27-13-20210212","doi-asserted-by":"crossref","first-page":"14037","DOI":"10.1073\/pnas.96.24.14037","article-title":"Differentially expressed protein Pdcd4 inhibits tumor promoter-induced neoplastic transformation.","volume":"96","author":"Cmarik","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R28-13-20210212","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1046\/j.1440-1827.1999.00995.x","article-title":"Novel human PDCD4 (H731) gene expressed in proliferative cells is expressed in the small duct epithelial cells of the breast as revealed by an anti-H731 antibody.","volume":"49","author":"Yoshinaga","year":"1999","journal-title":"Pathol Int"},{"key":"R29-13-20210212","first-page":"121","article-title":"Expression and identification of H731 gene product in HeLa cells.","volume":"1","author":"Yoshinaga","year":"1997","journal-title":"Res Comm Biochem Cell Mol Biol"},{"key":"R30-13-20210212","first-page":"109","article-title":"Isolation of a novel gene from a human cell line with Pr-28 MAb which recognizes a nuclear antigen involved in the cell cycle.","volume":"1","author":"Matsuhashi","year":"1997","journal-title":"Res Comm Biochem Cell Mol Biol"},{"key":"R31-13-20210212","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1158\/0008-5472.CAN-07-1719","article-title":"Translation inhibitor Pdcd4 is targeted for degradation during tumor promotion.","volume":"68","author":"Schmid","year":"2008","journal-title":"Cancer Res"},{"key":"R32-13-20210212","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.1158\/0008-5472.CAN-08-2334","article-title":"Programmed cell death protein 4 down-regulates Y-box binding protein-1 expression via a direct interaction with Twist1 to suppress cancer cell growth.","volume":"69","author":"Shiota","year":"2009","journal-title":"Cancer Res"},{"key":"R33-13-20210212","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.2174\/092986708785908987","article-title":"Phosphoregulation of Twist1 provides a mechanism of cell fate control.","volume":"15","author":"Firulli","year":"2008","journal-title":"Curr Med Chem"},{"issue":"supp 1A","key":"R34-13-20210212","first-page":"467","article-title":"Rosiglitazone modulates multiple signaling pathways in pancreatic beta cells and protects beta cells from the detrimental effects of free fatty acids.","volume":"57","author":"Landy","year":"2008","journal-title":"Diabetes"}],"container-title":["Pancreas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPA.0b013e3181f5f1ab","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T01:43:16Z","timestamp":1740534196000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006676-201101000-00013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/mpa.0b013e3181f5f1ab","relation":{},"ISSN":["0885-3177"],"issn-type":[{"type":"print","value":"0885-3177"}],"subject":[],"published":{"date-parts":[[2011,1]]}}}